ENCORAFENIB

ENCORAFENIB was reported 10191 times

ENCORAFENIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SEROUS RETINOPATHY 57 0.5429
1 SEROUS RETINAL DETACHMENT 360 0.4296
2 LESER-TRELAT SIGN 3 0.2727
3 DETACHMENT OF MACULAR RETINAL PIGMENT EPITHELIUM 4 0.0769
4 BRAF V600E MUTATION POSITIVE 4 0.0656
5 KERATOSIS FOLLICULAR 5 0.0641
6 MACULAR DETACHMENT 13 0.0537
7 BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT 4 0.0392
8 VOGT-KOYANAGI-HARADA DISEASE 8 0.0364
9 DYSPLASTIC NAEVUS 10 0.0277
10 OCULAR TOXICITY 29 0.0263
11 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 22 0.0247
12 LENTIGO 12 0.0242
13 TRANSIENT ACANTHOLYTIC DERMATOSIS 7 0.0238
14 CHLOROPSIA 3 0.0234
15 CENTRAL SEROUS CHORIORETINOPATHY 16 0.0234
16 BODY SURFACE AREA INCREASED 3 0.0233
17 COLOUR BLINDNESS ACQUIRED 8 0.0220
18 INTRACRANIAL TUMOUR HAEMORRHAGE 8 0.0207
19 EYE SYMPTOM 7 0.0196
20 SUBRETINAL FLUID 21 0.0192
21 METASTATIC MALIGNANT MELANOMA 43 0.0187
22 MELANOCYTIC NAEVUS 79 0.0180
23 PYOGENIC GRANULOMA 8 0.0172
24 CHORIORETINITIS 11 0.0171
25 SECOND PRIMARY MALIGNANCY 137 0.0165
26 BIFASCICULAR BLOCK 3 0.0160
27 NEOPLASM PROGRESSION 553 0.0159
28 ANASTOMOTIC HAEMORRHAGE 3 0.0158
29 LEUKODERMA 3 0.0151
30 KERATOACANTHOMA 10 0.0146
31 MALIGNANT MELANOMA STAGE 0 3 0.0144
32 LARGE INTESTINAL ULCER 39 0.0144
33 MECHANICAL ILEUS 8 0.0140
34 ACUTE POLYNEUROPATHY 4 0.0140
35 RETINAL OEDEMA 26 0.0136
36 XANTHOPSIA 5 0.0136
37 CARBOHYDRATE ANTIGEN 19-9 INCREASED 7 0.0132
38 ACROCHORDON 17 0.0128
39 RETINOPATHY 47 0.0126
40 COLORECTAL CANCER METASTATIC 29 0.0122
41 CREATINE KINASE INCREASED 9 0.0117
42 PACHYMENINGITIS 3 0.0115
43 HALO VISION 13 0.0115
44 RETROPERITONEAL LYMPHADENOPATHY 6 0.0114
45 DERMATITIS ACNEIFORM 68 0.0112
46 RETINAL DETACHMENT 102 0.0111
47 INTERTRIGO 6 0.0110
48 LYMPHOCYTIC HYPOPHYSITIS 3 0.0109
49 ENTEROCOLITIS BACTERIAL 3 0.0109
50 DEMYELINATING POLYNEUROPATHY 11 0.0107
51 CANDIDA SEPSIS 9 0.0100
52 IMMUNE-MEDIATED HEPATITIS 20 0.0098
53 TUMOUR ASSOCIATED FEVER 4 0.0098
54 PAPILLOMA 3 0.0095
55 MACULAR OEDEMA 52 0.0093
56 BLOOD CREATINE PHOSPHOKINASE DECREASED 3 0.0091
57 CHORIORETINOPATHY 13 0.0091
58 CUTANEOUS SYMPTOM 6 0.0088
59 LARGE INTESTINAL ULCER HAEMORRHAGE 3 0.0086
60 IMMUNE-MEDIATED NEPHRITIS 4 0.0085
61 CYSTOID MACULAR OEDEMA 16 0.0085
62 SUSPECTED OFF LABEL USE 37 0.0082
63 AUTOIMMUNE COLITIS 5 0.0078
64 CARCINOEMBRYONIC ANTIGEN INCREASED 15 0.0077
65 SMALL INTESTINE ULCER 5 0.0077
66 RETINITIS 13 0.0075
67 DYSCHROMATOPSIA 6 0.0072
68 HOSPICE CARE 71 0.0072
69 GLIOSIS 3 0.0070
70 RADIATION NECROSIS 4 0.0070
71 SEBORRHOEIC KERATOSIS 10 0.0069
72 IMMUNE-MEDIATED HYPOPHYSITIS 3 0.0067
73 ANASTOMOTIC ULCER 3 0.0065
74 METAMORPHOPSIA 12 0.0065
75 NEOPLASM RECURRENCE 22 0.0065
76 UVEITIS 87 0.0064
77 PRIMARY BILIARY CHOLANGITIS 3 0.0064
78 PULPITIS DENTAL 6 0.0064
79 BRAIN STEM HAEMORRHAGE 6 0.0063
80 HAEMOPERITONEUM 5 0.0062
81 COLON CANCER METASTATIC 10 0.0062
82 DUODENAL STENOSIS 3 0.0062
83 STARVATION 5 0.0060
84 AMYLASE INCREASED 22 0.0060
85 IRIDOCYCLITIS 18 0.0057
86 BRAIN OPERATION 13 0.0057
87 ILEAL STENOSIS 10 0.0056
88 EPHELIDES 3 0.0056
89 CELL DEATH 11 0.0055
90 PALMOPLANTAR KERATODERMA 4 0.0055
91 BODY TINEA 3 0.0054
92 TUMOUR LYSIS SYNDROME 47 0.0053
93 HYPOPITUITARISM 9 0.0052
94 INTESTINAL ULCER 8 0.0050
95 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 4 0.0050
96 BILE DUCT STENOSIS 6 0.0050
97 SKIN PAPILLOMA 20 0.0050
98 SKIN TOXICITY 28 0.0049
99 ILEAL ULCER 5 0.0049
100 IMMUNE-MEDIATED ENTEROCOLITIS 18 0.0049
101 BLOOD BILIRUBIN DECREASED 3 0.0049
102 PARONYCHIA 21 0.0048
103 LIPASE INCREASED 36 0.0047
104 BILIARY OBSTRUCTION 6 0.0046
105 MALIGNANT MELANOMA 62 0.0046
106 IMMUNE-MEDIATED HEPATIC DISORDER 9 0.0046
107 ABDOMINAL SEPSIS 4 0.0045
108 HYPOPHYSITIS 9 0.0045
109 HEPATIC CYTOLYSIS 56 0.0044
110 PERIPHERAL MOTOR NEUROPATHY 6 0.0043
111 TUNNEL VISION 8 0.0043
112 RETINAL DISORDER 11 0.0042
113 METASTASES TO CENTRAL NERVOUS SYSTEM 54 0.0042
114 SKIN TEXTURE ABNORMAL 4 0.0042
115 LYMPHADENECTOMY 4 0.0041
116 DUODENAL PERFORATION 4 0.0041
117 CARDIAC DYSFUNCTION 15 0.0040
118 THYROIDITIS 12 0.0040
119 ENTEROCOLITIS 23 0.0040
120 PERIPHERAL SENSORIMOTOR NEUROPATHY 5 0.0040
121 PULMONARY ARTERY THROMBOSIS 3 0.0039
122 STOMA SITE HAEMORRHAGE 6 0.0039
123 RETINAL TOXICITY 4 0.0039
124 LYMPHANGIOSIS CARCINOMATOSA 4 0.0038
125 COLITIS 143 0.0038
126 PERFORATION 3 0.0037
127 GRANULOMA SKIN 3 0.0037
128 BLOOD CREATINE PHOSPHOKINASE INCREASED 104 0.0036
129 PRERENAL FAILURE 5 0.0035
130 CANCER PAIN 9 0.0035
131 HYPERSENSITIVITY PNEUMONITIS 4 0.0035
132 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
133 HYPERKERATOSIS 18 0.0033
134 ORAL MUCOSA EROSION 4 0.0033
135 BLOOD BICARBONATE DECREASED 6 0.0032
136 METASTASES TO PERITONEUM 8 0.0032
137 DERMATITIS EXFOLIATIVE GENERALISED 11 0.0032
138 CANCER SURGERY 3 0.0031
139 ERYTHEMA NODOSUM 11 0.0031
140 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 73 0.0031
141 PHYSICAL DECONDITIONING 8 0.0031
142 METASTASES TO MENINGES 7 0.0031
143 LUNG OPACITY 8 0.0030
144 POLYNEUROPATHY 36 0.0030
145 PUSTULE 7 0.0030
146 GASTROINTESTINAL PERFORATION 12 0.0029
147 DIABETIC METABOLIC DECOMPENSATION 4 0.0029
148 ENTERITIS 18 0.0028
149 IMMUNE-MEDIATED LUNG DISEASE 5 0.0027
150 RASH MACULO-PAPULAR 61 0.0027
151 MALIGNANT NEOPLASM PROGRESSION 280 0.0027
152 GASTROINTESTINAL ULCER 6 0.0027
153 ENTEROCOLITIS HAEMORRHAGIC 4 0.0027
154 GUILLAIN-BARRE SYNDROME 13 0.0027
155 LARGE INTESTINAL HAEMORRHAGE 6 0.0027
156 GASTROINTESTINAL WALL THICKENING 4 0.0027
157 IMMUNE-MEDIATED HYPOTHYROIDISM 3 0.0027
158 CORTISOL DECREASED 3 0.0026
159 CALCULUS URINARY 4 0.0026
160 AORTIC THROMBOSIS 3 0.0026
161 ILEUS 32 0.0026
162 VITILIGO 6 0.0026
163 DUODENAL ULCER 18 0.0025
164 EJECTION FRACTION DECREASED 39 0.0025
165 EMBOLISM ARTERIAL 3 0.0025
166 OTITIS EXTERNA 3 0.0025
167 HYPOALBUMINAEMIA 19 0.0024
168 VITREOUS FLOATERS 24 0.0024
169 BLOOD MAGNESIUM DECREASED 21 0.0024
170 GAMMA-GLUTAMYLTRANSFERASE INCREASED 53 0.0024
171 ENTERITIS INFECTIOUS 4 0.0023
172 ACTINIC KERATOSIS 6 0.0023
173 VITREOUS DETACHMENT 5 0.0023
174 HEPATITIS 59 0.0023
175 BRAIN NEOPLASM 21 0.0023
176 HEPATIC FUNCTION ABNORMAL 85 0.0023
177 SKIN HYPOPIGMENTATION 4 0.0023
178 FACIAL PARALYSIS 19 0.0022
179 BLOOD LOSS ANAEMIA 5 0.0022
180 HYDROCEPHALUS 12 0.0022
181 COLON CANCER 32 0.0021
182 LIVER FUNCTION TEST INCREASED 46 0.0021
183 PNEUMONITIS 58 0.0021
184 PRODUCT USE IN UNAPPROVED INDICATION 523 0.0021
185 PIGMENTATION DISORDER 13 0.0021
186 TUMOUR HAEMORRHAGE 6 0.0021
187 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
188 LIVER DISORDER 93 0.0021
189 DUODENAL ULCER HAEMORRHAGE 6 0.0021
190 CHOLANGITIS 13 0.0021
191 NEPHRITIS 7 0.0021
192 CEREBRAL HAEMATOMA 7 0.0021
193 VISUAL FIELD DEFECT 15 0.0021
194 DISEASE PROGRESSION 245 0.0021
195 ARTERIAL THROMBOSIS 4 0.0021
196 GLOMERULONEPHRITIS 5 0.0020
197 NORMOCYTIC ANAEMIA 3 0.0020
198 EYE OEDEMA 5 0.0020
199 LARGE INTESTINE PERFORATION 14 0.0020
200 METABOLIC ENCEPHALOPATHY 6 0.0020
201 SQUAMOUS CELL CARCINOMA OF SKIN 12 0.0020
202 SMALL INTESTINAL HAEMORRHAGE 4 0.0020
203 ASTIGMATISM 3 0.0020
204 INTESTINAL PERFORATION 22 0.0020
205 BLOOD LACTATE DEHYDROGENASE INCREASED 31 0.0020
206 CHOLANGITIS SCLEROSING 4 0.0019
207 HYPOMAGNESAEMIA 27 0.0019
208 NEOPLASM SKIN 3 0.0019
209 CHOLESTASIS 37 0.0019
210 ATRIAL TACHYCARDIA 4 0.0019
211 FOREIGN BODY IN THROAT 6 0.0019
212 HYPERPYREXIA 8 0.0019
213 OPTIC NERVE DISORDER 3 0.0019
214 GASTROINTESTINAL TOXICITY 9 0.0019
215 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 14 0.0019
216 LIVER ABSCESS 6 0.0018
217 BACTERIAL TEST POSITIVE 4 0.0018
218 LARGE INTESTINAL OBSTRUCTION 4 0.0018
219 ANAL HAEMORRHAGE 5 0.0018
220 MYOSITIS 16 0.0018
221 MENINGITIS ASEPTIC 8 0.0018
222 COLITIS ISCHAEMIC 12 0.0018
223 HEPATORENAL SYNDROME 3 0.0018
224 RENAL TUBULAR DISORDER 5 0.0018
225 PYREXIA 615 0.0018
226 PHOTOSENSITIVITY REACTION 29 0.0018
227 IRON DEFICIENCY ANAEMIA 16 0.0017
228 PRODUCT PRESCRIBING ERROR 41 0.0017
229 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 4 0.0017
230 METASTASES TO LIVER 30 0.0017
231 JAUNDICE CHOLESTATIC 6 0.0017
232 POLYMYOSITIS 3 0.0017
233 URINARY TRACT OBSTRUCTION 4 0.0017
234 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
235 PRODUCT SIZE ISSUE 9 0.0017
236 ATYPICAL PNEUMONIA 5 0.0017
237 OPHTHALMIC HERPES ZOSTER 3 0.0017
238 BRAIN OEDEMA 21 0.0017
239 PULSE ABNORMAL 4 0.0017
240 VISION BLURRED 228 0.0017
241 PANNICULITIS 4 0.0017
242 ADRENAL INSUFFICIENCY 20 0.0016
243 MENINGITIS 11 0.0016
244 VISUAL IMPAIRMENT 204 0.0016
245 INTESTINAL OBSTRUCTION 62 0.0016
246 ESSENTIAL HYPERTENSION 3 0.0016
247 ASPARTATE AMINOTRANSFERASE INCREASED 87 0.0016
248 SKIN HYPERPIGMENTATION 14 0.0016
249 TASTE DISORDER 33 0.0016
250 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
251 HYPERNATRAEMIA 8 0.0016
252 ENCEPHALITIS 11 0.0016
253 EYE DISORDER 52 0.0016
254 NON-CARDIAC CHEST PAIN 5 0.0016
255 BRAIN NEOPLASM MALIGNANT 7 0.0016
256 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
257 ACUTE KIDNEY INJURY 237 0.0015
258 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
259 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
260 HYPOGEUSIA 3 0.0015
261 RENAL IMPAIRMENT 128 0.0015
262 PRODUCT USE COMPLAINT 24 0.0015
263 LARGE INTESTINAL STENOSIS 3 0.0015
264 ALANINE AMINOTRANSFERASE INCREASED 92 0.0015
265 HYPERLACTACIDAEMIA 4 0.0015
266 MUCOSAL DRYNESS 3 0.0015
267 SQUAMOUS CELL CARCINOMA 14 0.0015
268 THERAPY PARTIAL RESPONDER 23 0.0015
269 SARCOIDOSIS 7 0.0015
270 DERMATITIS PSORIASIFORM 3 0.0015
271 MELAENA 32 0.0015
272 BLOOD CREATININE ABNORMAL 5 0.0014
273 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
274 BLOOD CREATININE INCREASED 94 0.0014
275 AUTOIMMUNE HEPATITIS 10 0.0014
276 THERAPY CHANGE 14 0.0014
277 PHOTOPSIA 9 0.0014
278 EAR SWELLING 3 0.0014
279 NEUROLOGICAL SYMPTOM 8 0.0014
280 TRANSAMINASES INCREASED 31 0.0014
281 DEATH 1201 0.0014
282 ERYTHEMA MULTIFORME 13 0.0014
283 HYPOACUSIS 60 0.0014
284 METASTATIC NEOPLASM 6 0.0014
285 METASTASES TO LUNG 16 0.0014
286 HYPOTHYROIDISM 44 0.0014
287 DECREASED APPETITE 320 0.0014
288 DYSPHAGIA 130 0.0014
289 ENDOCARDITIS 7 0.0014
290 ABDOMINAL ABSCESS 6 0.0014
291 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
292 HEPATOCELLULAR INJURY 19 0.0013
293 ELECTROCARDIOGRAM QT PROLONGED 48 0.0013
294 IRON DEFICIENCY 6 0.0013
295 IRITIS 4 0.0013
296 HAEMOGLOBIN INCREASED 6 0.0013
297 OFF LABEL USE 1142 0.0013
298 HAIR GROWTH ABNORMAL 9 0.0013
299 NEUROLOGICAL DECOMPENSATION 3 0.0013
300 LOCALISED OEDEMA 6 0.0013
301 RENAL FUNCTION TEST ABNORMAL 6 0.0013
302 PANCREATITIS ACUTE 29 0.0013
303 PATELLA FRACTURE 3 0.0013
304 BASAL CELL CARCINOMA 20 0.0013
305 ESCHERICHIA BACTERAEMIA 3 0.0013
306 BLOOD SODIUM DECREASED 24 0.0013
307 C-REACTIVE PROTEIN INCREASED 46 0.0013
308 NEUROPATHY PERIPHERAL 120 0.0013
309 HEPATOTOXICITY 28 0.0013
310 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
311 TUMOUR MARKER INCREASED 6 0.0012
312 GASTROINTESTINAL OBSTRUCTION 3 0.0012
313 DRUG-INDUCED LIVER INJURY 39 0.0012
314 DRUG ERUPTION 22 0.0012
315 RASH PUSTULAR 9 0.0012
316 RECURRENT CANCER 5 0.0012
317 SMALL INTESTINAL OBSTRUCTION 15 0.0012
318 NEOPLASM 14 0.0012
319 HYPERURICAEMIA 5 0.0012
320 CHILLS 142 0.0012
321 EMBOLISM 10 0.0012
322 THYROID FUNCTION TEST ABNORMAL 5 0.0012
323 SKIN DISORDER 40 0.0012
324 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
325 METASTASES TO SPINE 4 0.0012
326 INTESTINAL STENOSIS 5 0.0012
327 METASTASES TO LYMPH NODES 8 0.0012
328 ABDOMINAL INFECTION 3 0.0012
329 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
330 HEPATITIS CHOLESTATIC 7 0.0012
331 RENAL DISORDER 54 0.0012
332 LYMPHOEDEMA 8 0.0012
333 INTERSTITIAL LUNG DISEASE 56 0.0012
334 BRAIN FOG 18 0.0011
335 BLOOD ALBUMIN DECREASED 9 0.0011
336 DEHYDRATION 151 0.0011
337 BLOOD CREATINE INCREASED 5 0.0011
338 ILLNESS 116 0.0011
339 CONJUNCTIVAL HYPERAEMIA 4 0.0011
340 METASTASIS 8 0.0011
341 THERAPY INTERRUPTED 80 0.0011
342 GASTROINTESTINAL INFECTION 10 0.0011
343 RASH 486 0.0011
344 HYPERTHYROIDISM 16 0.0011
345 GASTRIC ULCER 21 0.0011
346 NAUSEA 872 0.0011
347 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
348 BLINDNESS TRANSIENT 8 0.0011
349 MACULE 3 0.0011
350 RHABDOMYOLYSIS 45 0.0011
351 HEPATITIS ACUTE 7 0.0011
352 DIARRHOEA HAEMORRHAGIC 10 0.0011
353 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
354 PROTEIN TOTAL DECREASED 4 0.0011
355 COLITIS MICROSCOPIC 5 0.0011
356 CARDIAC TAMPONADE 5 0.0011
357 INTERNAL HAEMORRHAGE 12 0.0010
358 ANAEMIA 200 0.0010
359 HEART VALVE INCOMPETENCE 3 0.0010
360 VOMITING 488 0.0010
361 FEEDING DISORDER 21 0.0010
362 RASH VESICULAR 5 0.0010
363 PROCEDURAL HAEMORRHAGE 4 0.0010
364 FATIGUE 795 0.0010
365 ASCITES 30 0.0010
366 BLOOD IRON DECREASED 12 0.0010
367 BACTERAEMIA 12 0.0010
368 DIARRHOEA 652 0.0010
369 ORGANISING PNEUMONIA 5 0.0010
370 HYPERTRANSAMINASAEMIA 7 0.0010
371 ULCER 16 0.0010
372 CEREBRAL HAEMORRHAGE 36 0.0010
373 PANCREATITIS 53 0.0010
374 OBSTRUCTION 4 0.0010
375 HEPATIC ENZYME INCREASED 68 0.0010
376 ARTERIOSPASM CORONARY 4 0.0010
377 VISUAL ACUITY REDUCED 33 0.0010
378 CONSTIPATION 216 0.0010
379 PROSTATITIS 3 0.0010
380 DYSAESTHESIA 3 0.0010
381 RECTAL HAEMORRHAGE 42 0.0010
382 MYALGIA 166 0.0010
383 HYPERBILIRUBINAEMIA 10 0.0010
384 PRODUCT DOSE OMISSION 63 0.0010
385 BLOOD BILIRUBIN INCREASED 26 0.0010
386 BLOOD BLISTER 3 0.0010
387 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
388 POLYARTHRITIS 5 0.0009
389 SKIN LESION 26 0.0009
390 CARDIOMYOPATHY 14 0.0009
391 ELECTROLYTE IMBALANCE 11 0.0009
392 POLYMYALGIA RHEUMATICA 3 0.0009
393 FEBRILE BONE MARROW APLASIA 4 0.0009
394 PEMPHIGOID 7 0.0009
395 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
396 SKIN FISSURES 18 0.0009
397 BONE CANCER 4 0.0009
398 HEPATIC NEOPLASM 3 0.0009
399 RENAL TUBULAR NECROSIS 9 0.0009
400 THYROID CANCER 11 0.0009
401 SKIN DISCOLOURATION 42 0.0009
402 HYPOKALAEMIA 42 0.0009
403 PERICARDIAL EFFUSION 21 0.0009
404 BLINDNESS 37 0.0009
405 LYMPHOCYTE COUNT DECREASED 16 0.0009
406 PHOTOPHOBIA 17 0.0009
407 GASTRIC ULCER HAEMORRHAGE 5 0.0009
408 SKIN MASS 6 0.0009
409 CYTOKINE RELEASE SYNDROME 18 0.0009
410 URINARY TRACT DISORDER 4 0.0009
411 HEMIPARESIS 15 0.0009
412 NEPHROTIC SYNDROME 6 0.0009
413 MYOCARDITIS 10 0.0009
414 UROSEPSIS 8 0.0009
415 GRANULOMA 3 0.0009
416 SEIZURE 100 0.0009
417 ABDOMINAL PAIN 200 0.0009
418 SKIN TIGHTNESS 4 0.0008
419 PULMONARY TOXICITY 6 0.0008
420 FACIAL PARESIS 3 0.0008
421 CHOLECYSTITIS 10 0.0008
422 GENERAL PHYSICAL HEALTH DETERIORATION 97 0.0008
423 THERAPY CESSATION 43 0.0008
424 DERMATITIS BULLOUS 6 0.0008
425 MONOCYTE COUNT INCREASED 3 0.0008
426 GASTROINTESTINAL PAIN 9 0.0008
427 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
428 MYOPATHY 7 0.0008
429 GENERALISED OEDEMA 10 0.0008
430 PRESCRIBED UNDERDOSE 16 0.0008
431 HEPATIC ENZYME ABNORMAL 4 0.0008
432 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
433 HYPONATRAEMIA 45 0.0008
434 METASTASES TO BONE 13 0.0008
435 ARTHRALGIA 329 0.0008
436 PATHOLOGICAL FRACTURE 4 0.0008
437 CARDIOTOXICITY 7 0.0008
438 GINGIVAL DISORDER 3 0.0008
439 HYPERKALAEMIA 27 0.0008
440 CANDIDA INFECTION 13 0.0008
441 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
442 PARTIAL SEIZURES 4 0.0008
443 NAIL DISCOLOURATION 3 0.0008
444 COVID-19 PNEUMONIA 9 0.0008
445 HAEMATOCHEZIA 42 0.0008
446 FOOD POISONING 4 0.0007
447 PRODUCT USE ISSUE 139 0.0007
448 ULCER HAEMORRHAGE 5 0.0007
449 ACNE 56 0.0007
450 COLITIS ULCERATIVE 33 0.0007
451 SHOCK HAEMORRHAGIC 6 0.0007
452 PERIPHERAL ISCHAEMIA 3 0.0007
453 EYE INFLAMMATION 7 0.0007
454 HEPATIC FAILURE 22 0.0007
455 ESCHERICHIA INFECTION 6 0.0007
456 APHASIA 22 0.0007
457 LEG AMPUTATION 3 0.0007
458 AORTIC DISSECTION 3 0.0007
459 EXTRASYSTOLES 5 0.0007
460 ONYCHOMADESIS 3 0.0007
461 NEPHROPATHY TOXIC 8 0.0007
462 OCULAR DISCOMFORT 8 0.0007
463 BLOOD TEST ABNORMAL 10 0.0007
464 HYPOPHAGIA 18 0.0007
465 HEPATIC PAIN 3 0.0007
466 RASH PRURITIC 38 0.0007
467 MALAISE 306 0.0007
468 ASTHENIA 262 0.0007
469 SKIN CANCER 15 0.0007
470 TOXIC SKIN ERUPTION 7 0.0007
471 HORDEOLUM 3 0.0007
472 STRESS CARDIOMYOPATHY 4 0.0007
473 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
474 LABORATORY TEST ABNORMAL 20 0.0007
475 BRADYKINESIA 4 0.0007
476 CEREBRAL DISORDER 5 0.0007
477 PLEURAL EFFUSION 41 0.0007
478 HAIR TEXTURE ABNORMAL 9 0.0007
479 RENAL FAILURE 89 0.0007
480 HYDRONEPHROSIS 5 0.0007
481 PAPILLOEDEMA 3 0.0007
482 OROPHARYNGEAL DISCOMFORT 6 0.0007
483 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 17 0.0007
484 TENDON PAIN 5 0.0007
485 OPTIC NEURITIS 6 0.0007
486 RENAL PAIN 7 0.0007
487 TROPONIN INCREASED 5 0.0007
488 EPILEPSY 20 0.0007
489 FACE OEDEMA 11 0.0007
490 DRUG INTOLERANCE 63 0.0007
491 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
492 SPEECH DISORDER 34 0.0006
493 GASTRITIS 17 0.0006
494 SKIN LACERATION 7 0.0006
495 PERFORMANCE STATUS DECREASED 3 0.0006
496 PULMONARY THROMBOSIS 7 0.0006
497 SEPSIS 71 0.0006
498 HAEMATOTOXICITY 6 0.0006
499 RASH ERYTHEMATOUS 30 0.0006
500 ATRIAL FLUTTER 5 0.0006
501 HYPERCHOLESTEROLAEMIA 6 0.0006
502 DRY EYE 31 0.0006
503 DERMATITIS 13 0.0006
504 INCOHERENT 4 0.0006
505 AUTOIMMUNE DISORDER 6 0.0006
506 HYPERVOLAEMIA 3 0.0006
507 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
508 SPINAL COMPRESSION FRACTURE 5 0.0006
509 PROTEIN URINE PRESENT 3 0.0006
510 CARDIAC FAILURE ACUTE 4 0.0006
511 HYPERAMMONAEMIA 3 0.0006
512 FLUID INTAKE REDUCED 3 0.0006
513 FAECES DISCOLOURED 13 0.0006
514 CARDIAC FAILURE 48 0.0006
515 INTENTIONAL DOSE OMISSION 17 0.0006
516 DRUG TOLERANCE 3 0.0006
517 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
518 MOTOR DYSFUNCTION 6 0.0006
519 INFUSION RELATED REACTION 39 0.0006
520 ORAL PAIN 13 0.0006
521 PULMONARY EMBOLISM 55 0.0006
522 HYPOTENSION 116 0.0006
523 ABDOMINAL PAIN UPPER 119 0.0006
524 FAILURE TO THRIVE 3 0.0006
525 PERIORBITAL OEDEMA 3 0.0006
526 APLASTIC ANAEMIA 3 0.0006
527 GASTROINTESTINAL HAEMORRHAGE 48 0.0006
528 VERTIGO 35 0.0006
529 APHONIA 8 0.0006
530 CYTOPENIA 7 0.0006
531 OEDEMA 31 0.0006
532 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
533 LYMPHADENOPATHY 20 0.0006
534 RETCHING 12 0.0006
535 DRY SKIN 75 0.0006
536 RETINAL HAEMORRHAGE 4 0.0006
537 URINARY TRACT INFECTION 95 0.0006
538 HAEMOGLOBIN DECREASED 57 0.0006
539 BLOOD POTASSIUM INCREASED 9 0.0006
540 LEUKOCYTOSIS 10 0.0006
541 PRODUCT PRESCRIBING ISSUE 12 0.0006
542 UNDERDOSE 40 0.0005
543 PERIPHERAL SWELLING 84 0.0005
544 DEAFNESS UNILATERAL 3 0.0005
545 ABDOMINAL DISCOMFORT 91 0.0005
546 DENTAL CARIES 6 0.0005
547 SENSITIVE SKIN 4 0.0005
548 HYPOPHOSPHATAEMIA 4 0.0005
549 NERVE INJURY 6 0.0005
550 MALNUTRITION 6 0.0005
551 GASTROINTESTINAL DISORDER 48 0.0005
552 HAEMORRHAGE INTRACRANIAL 8 0.0005
553 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
554 NEURALGIA 13 0.0005
555 BLOOD CALCIUM DECREASED 6 0.0005
556 BLOOD POTASSIUM DECREASED 16 0.0005
557 EYE INFECTION 6 0.0005
558 COLECTOMY 3 0.0005
559 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
560 FRACTURE 10 0.0005
561 THROMBOCYTOPENIA 59 0.0005
562 ALOPECIA 103 0.0005
563 BOWEL MOVEMENT IRREGULARITY 4 0.0005
564 HYPERGLYCAEMIA 19 0.0005
565 PAIN OF SKIN 14 0.0005
566 MOUTH SWELLING 3 0.0005
567 EATING DISORDER 11 0.0005
568 DYSURIA 19 0.0005
569 EYELID OEDEMA 6 0.0005
570 LIVER FUNCTION TEST ABNORMAL 15 0.0005
571 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15 0.0005
572 COLD SWEAT 9 0.0005
573 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
574 URINARY RETENTION 17 0.0005
575 WEIGHT DECREASED 142 0.0005
576 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
577 ATAXIA 6 0.0005
578 PNEUMOTHORAX 8 0.0005
579 ATRIAL FIBRILLATION 49 0.0005
580 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
581 BLINDNESS UNILATERAL 7 0.0005
582 STENT PLACEMENT 4 0.0005
583 MYASTHENIA GRAVIS 4 0.0005
584 MUSCLE DISORDER 4 0.0005
585 POST PROCEDURAL INFECTION 4 0.0005
586 RASH PAPULAR 11 0.0005
587 SLUGGISHNESS 5 0.0005
588 SUBDURAL HAEMATOMA 7 0.0005
589 PARALYSIS 7 0.0005
590 ENCEPHALOPATHY 12 0.0005
591 ANGINA PECTORIS 14 0.0005
592 HICCUPS 4 0.0005
593 HYPERCALCAEMIA 6 0.0005
594 OLIGURIA 3 0.0005
595 ACUTE CORONARY SYNDROME 4 0.0005
596 DYSSTASIA 14 0.0005
597 HYPOCALCAEMIA 9 0.0005
598 ACUTE MYOCARDIAL INFARCTION 14 0.0005
599 SKIN PLAQUE 4 0.0005
600 BLOOD URINE PRESENT 9 0.0005
601 INCONTINENCE 5 0.0005
602 FULL BLOOD COUNT ABNORMAL 5 0.0005
603 CATARACT 28 0.0005
604 PLATELET COUNT DECREASED 50 0.0005
605 ACUTE RESPIRATORY FAILURE 9 0.0005
606 PRURITUS 179 0.0005
607 DEMENTIA 13 0.0005
608 INFECTION 67 0.0005
609 DYSPHONIA 27 0.0005
610 PYELONEPHRITIS 4 0.0005
611 HAEMORRHOIDS 9 0.0005
612 HAEMORRHAGE 48 0.0005
613 MUCOSAL INFLAMMATION 12 0.0005
614 RASH MACULAR 16 0.0005
615 DEVICE RELATED INFECTION 7 0.0005
616 APPETITE DISORDER 3 0.0005
617 DYSPNOEA EXERTIONAL 17 0.0005
618 HEAVY MENSTRUAL BLEEDING 4 0.0004
619 BONE PAIN 26 0.0004
620 OEDEMA PERIPHERAL 54 0.0004
621 OCULAR HYPERAEMIA 21 0.0004
622 MUSCULAR WEAKNESS 50 0.0004
623 HAEMATURIA 15 0.0004
624 ECCHYMOSIS 3 0.0004
625 ONYCHOCLASIS 3 0.0004
626 PNEUMONIA BACTERIAL 4 0.0004
627 THROMBOSIS 35 0.0004
628 PERITONITIS 9 0.0004
629 CONFUSIONAL STATE 70 0.0004
630 DIVERTICULITIS 12 0.0004
631 CONJUNCTIVITIS 8 0.0004
632 DEEP VEIN THROMBOSIS 28 0.0004
633 AGRANULOCYTOSIS 8 0.0004
634 STOMATITIS 26 0.0004
635 SPINAL PAIN 5 0.0004
636 MUSCLE SPASMS 78 0.0004
637 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
638 ADVERSE EVENT 39 0.0004
639 ADVERSE DRUG REACTION 38 0.0004
640 BACK PAIN 98 0.0004
641 BLOOD PRESSURE DECREASED 28 0.0004
642 JOINT STIFFNESS 11 0.0004
643 GAIT INABILITY 14 0.0004
644 MACULAR DEGENERATION 5 0.0004
645 CELLULITIS 21 0.0004
646 POST PROCEDURAL COMPLICATION 8 0.0004
647 SEPTIC SHOCK 18 0.0004
648 FAECES SOFT 3 0.0004
649 COVID-19 72 0.0004
650 MOUTH HAEMORRHAGE 3 0.0004
651 PULMONARY OEDEMA 18 0.0004
652 HAIR COLOUR CHANGES 5 0.0004
653 GENERAL SYMPTOM 3 0.0004
654 EOSINOPHILIA 7 0.0004
655 PRODUCT PHYSICAL ISSUE 8 0.0004
656 PERITONITIS BACTERIAL 4 0.0004
657 FEELING COLD 11 0.0004
658 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
659 HYPERTHERMIA 3 0.0004
660 ABDOMINAL DISTENSION 41 0.0004
661 SUBARACHNOID HAEMORRHAGE 4 0.0004
662 FEBRILE NEUTROPENIA 26 0.0004
663 ERECTILE DYSFUNCTION 10 0.0004
664 HELICOBACTER INFECTION 4 0.0004
665 ATRIOVENTRICULAR BLOCK 3 0.0004
666 FLATULENCE 22 0.0004
667 EPISTAXIS 29 0.0004
668 PAIN 237 0.0004
669 MEMORY IMPAIRMENT 53 0.0004
670 RESTLESS LEGS SYNDROME 7 0.0004
671 RED BLOOD CELL COUNT DECREASED 11 0.0004
672 TENDERNESS 4 0.0004
673 HYPERSOMNIA 11 0.0004
674 NODULE 5 0.0004
675 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
676 TRANSFUSION 4 0.0004
677 SARS-COV-2 TEST POSITIVE 5 0.0004
678 EYE HAEMORRHAGE 5 0.0004
679 CARDIAC DISORDER 35 0.0004
680 LIVER INJURY 9 0.0004
681 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
682 POLYURIA 3 0.0004
683 VENTRICULAR TACHYCARDIA 6 0.0004
684 PAIN IN EXTREMITY 107 0.0004
685 ERUCTATION 7 0.0004
686 PRESCRIBED OVERDOSE 7 0.0004
687 HYPERSENSITIVITY 67 0.0004
688 VENTRICULAR FIBRILLATION 4 0.0004
689 SKIN INFECTION 4 0.0004
690 CHROMATURIA 8 0.0004
691 LYMPHOPENIA 5 0.0004
692 NEUTROPENIA 48 0.0004
693 CIRCULATORY COLLAPSE 6 0.0004
694 JOINT SWELLING 42 0.0003
695 SHOCK 8 0.0003
696 GASTRIC HAEMORRHAGE 4 0.0003
697 RASH GENERALISED 9 0.0003
698 LUNG DISORDER 17 0.0003
699 MUSCLE STRAIN 3 0.0003
700 DIPLOPIA 9 0.0003
701 HYPERTENSION 73 0.0003
702 BODY TEMPERATURE INCREASED 7 0.0003
703 COGNITIVE DISORDER 16 0.0003
704 GASTROENTERITIS 5 0.0003
705 GROIN PAIN 3 0.0003
706 NIGHT SWEATS 11 0.0003
707 GRIP STRENGTH DECREASED 3 0.0003
708 FACIAL PAIN 3 0.0003
709 THROAT TIGHTNESS 9 0.0003
710 ERYTHEMA 68 0.0003
711 VIRAL INFECTION 11 0.0003
712 ARTHRITIS 26 0.0003
713 PRESYNCOPE 8 0.0003
714 DISORIENTATION 13 0.0003
715 ANAPHYLACTIC REACTION 18 0.0003
716 HOSPITALISATION 50 0.0003
717 OVARIAN CANCER 3 0.0003
718 THYROID DISORDER 5 0.0003
719 BALANCE DISORDER 28 0.0003
720 TENDONITIS 5 0.0003
721 EYE SWELLING 12 0.0003
722 CYST 4 0.0003
723 MENTAL DISORDER 14 0.0003
724 PRODUCT DISPENSING ERROR 7 0.0003
725 TOOTH EXTRACTION 4 0.0003
726 APPENDICITIS 3 0.0003
727 HEADACHE 201 0.0003
728 PNEUMONIA ASPIRATION 8 0.0003
729 SKIN EXFOLIATION 27 0.0003
730 LOSS OF CONSCIOUSNESS 41 0.0003
731 NEUTROPHIL COUNT DECREASED 13 0.0003
732 ARRHYTHMIA 15 0.0003
733 MUSCULOSKELETAL DISORDER 6 0.0003
734 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
735 POLLAKIURIA 13 0.0003
736 GLAUCOMA 6 0.0003
737 ROTATOR CUFF SYNDROME 4 0.0003
738 ATELECTASIS 3 0.0003
739 HERNIA 6 0.0003
740 ANAPHYLACTIC SHOCK 8 0.0003
741 SYNCOPE 31 0.0003
742 DIZZINESS POSTURAL 3 0.0003
743 MUSCLE TIGHTNESS 5 0.0003
744 INTENTIONAL PRODUCT MISUSE 27 0.0003
745 CHOKING 6 0.0003
746 CEREBROVASCULAR ACCIDENT 52 0.0003
747 PLATELET COUNT INCREASED 4 0.0003
748 KIDNEY INFECTION 6 0.0003
749 NEPHROLITHIASIS 14 0.0003
750 ORAL CANDIDIASIS 4 0.0003
751 MUSCLE TWITCHING 7 0.0003
752 IMMUNE SYSTEM DISORDER 4 0.0003
753 HEART RATE INCREASED 30 0.0003
754 CONDITION AGGRAVATED 92 0.0003
755 BLOOD PRESSURE ABNORMAL 6 0.0003
756 ADVERSE REACTION 4 0.0003
757 BLOOD UREA INCREASED 5 0.0003
758 JOINT RANGE OF MOTION DECREASED 4 0.0003
759 LACRIMATION INCREASED 9 0.0003
760 JAUNDICE 8 0.0003
761 DRUG INTERACTION 47 0.0003
762 GINGIVAL BLEEDING 4 0.0003
763 INFLAMMATION 15 0.0003
764 MUSCULOSKELETAL DISCOMFORT 5 0.0003
765 INSOMNIA 77 0.0003
766 HYPOAESTHESIA 43 0.0003
767 HAEMOPTYSIS 8 0.0003
768 CEREBRAL INFARCTION 7 0.0003
769 DYSPNOEA 162 0.0003
770 NEUROTOXICITY 5 0.0003
771 BLISTER 16 0.0003
772 NEOPLASM MALIGNANT 19 0.0003
773 SOMNOLENCE 57 0.0003
774 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
775 CYSTITIS 9 0.0003
776 DIALYSIS 4 0.0003
777 PNEUMONIA 91 0.0003
778 DIZZINESS 140 0.0003
779 AGEUSIA 7 0.0003
780 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
781 OESOPHAGITIS 3 0.0003
782 BONE DISORDER 5 0.0003
783 ASPIRATION 3 0.0003
784 PRODUCTIVE COUGH 13 0.0003
785 PULMONARY MASS 4 0.0003
786 DEAFNESS 7 0.0003
787 COUGH 75 0.0003
788 RESPIRATORY DISORDER 8 0.0003
789 INFLUENZA LIKE ILLNESS 22 0.0003
790 MITRAL VALVE INCOMPETENCE 3 0.0003
791 DYSPEPSIA 26 0.0003
792 BLOOD COUNT ABNORMAL 4 0.0003
793 PROTEINURIA 5 0.0003
794 URTICARIA 44 0.0003
795 LIMB DISCOMFORT 8 0.0003
796 MUSCULOSKELETAL CHEST PAIN 4 0.0003
797 HEART RATE DECREASED 9 0.0003
798 FALL 85 0.0003
799 MENTAL STATUS CHANGES 7 0.0003
800 ARTHROPATHY 14 0.0003
801 SCIATICA 4 0.0003
802 METABOLIC ACIDOSIS 8 0.0002
803 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
804 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
805 EYE PAIN 14 0.0002
806 PARAESTHESIA 39 0.0002
807 MENTAL IMPAIRMENT 6 0.0002
808 NOCTURIA 3 0.0002
809 DRY MOUTH 20 0.0002
810 ACCIDENTAL OVERDOSE 9 0.0002
811 AMNESIA 16 0.0002
812 DEPRESSED MOOD 13 0.0002
813 SWELLING 23 0.0002
814 PRODUCT DOSE OMISSION ISSUE 72 0.0002
815 CARDIOMEGALY 3 0.0002
816 HERPES ZOSTER 14 0.0002
817 LIP SWELLING 8 0.0002
818 PULMONARY HYPERTENSION 5 0.0002
819 CONTUSION 23 0.0002
820 PERICARDITIS 4 0.0002
821 OROPHARYNGEAL PAIN 22 0.0002
822 TYPE 2 DIABETES MELLITUS 8 0.0002
823 ABDOMINAL PAIN LOWER 6 0.0002
824 HALLUCINATION, VISUAL 5 0.0002
825 TACHYCARDIA 21 0.0002
826 DRUG RESISTANCE 6 0.0002
827 GASTRIC DISORDER 8 0.0002
828 POOR QUALITY SLEEP 5 0.0002
829 SKIN ULCER 6 0.0002
830 DISEASE RECURRENCE 11 0.0002
831 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
832 SWELLING FACE 15 0.0002
833 ECZEMA 12 0.0002
834 DYSMENORRHOEA 3 0.0002
835 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
836 HYPERHIDROSIS 29 0.0002
837 NERVOUS SYSTEM DISORDER 7 0.0002
838 ISCHAEMIC STROKE 4 0.0002
839 GALLBLADDER DISORDER 4 0.0002
840 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
841 PALPITATIONS 26 0.0002
842 ACUTE HEPATIC FAILURE 3 0.0002
843 RESPIRATORY FAILURE 16 0.0002
844 CHEST PAIN 40 0.0002
845 ORAL DISCOMFORT 3 0.0002
846 INFLUENZA 24 0.0002
847 PANCYTOPENIA 12 0.0002
848 WOUND 6 0.0002
849 MASS 3 0.0002
850 GAIT DISTURBANCE 41 0.0002
851 CARPAL TUNNEL SYNDROME 3 0.0002
852 CHOLELITHIASIS 7 0.0002
853 IMPAIRED HEALING 7 0.0002
854 INCREASED APPETITE 4 0.0002
855 CARDIOGENIC SHOCK 3 0.0002
856 LETHARGY 12 0.0002
857 DIABETIC KETOACIDOSIS 5 0.0002
858 PARAESTHESIA ORAL 3 0.0002
859 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
860 FLUSHING 21 0.0002
861 CARDIAC ARREST 17 0.0002
862 APATHY 3 0.0002
863 SURGERY 12 0.0002
864 BLOOD PRESSURE INCREASED 31 0.0002
865 URINARY INCONTINENCE 6 0.0002
866 DYSGEUSIA 15 0.0002
867 HAEMATOCRIT DECREASED 4 0.0002
868 DELIRIUM 7 0.0002
869 TOXICITY TO VARIOUS AGENTS 34 0.0002
870 SPINAL FRACTURE 4 0.0002
871 HYPOAESTHESIA ORAL 3 0.0002
872 SLEEP DISORDER 14 0.0002
873 HAEMATEMESIS 5 0.0002
874 CARDIOVASCULAR DISORDER 5 0.0002
875 FLUID RETENTION 10 0.0002
876 FEELING ABNORMAL 47 0.0002
877 MOBILITY DECREASED 14 0.0002
878 LUNG NEOPLASM MALIGNANT 8 0.0002
879 MYELOSUPPRESSION 7 0.0002
880 MUSCULOSKELETAL PAIN 10 0.0002
881 CYANOSIS 3 0.0002
882 HALLUCINATION, AUDITORY 3 0.0002
883 OSTEOARTHRITIS 8 0.0002
884 ABSCESS 3 0.0002
885 BLOOD GLUCOSE DECREASED 9 0.0002
886 MOVEMENT DISORDER 6 0.0002
887 CARDIAC FAILURE CONGESTIVE 15 0.0002
888 HALLUCINATION 14 0.0002
889 DISTURBANCE IN ATTENTION 10 0.0002
890 BURNING SENSATION 13 0.0002
891 PRURITUS GENERALISED 4 0.0002
892 BACK DISORDER 3 0.0002
893 MYOCARDIAL INFARCTION 32 0.0002
894 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
895 STEVENS-JOHNSON SYNDROME 4 0.0002
896 OXYGEN SATURATION DECREASED 10 0.0002
897 HEART RATE IRREGULAR 4 0.0002
898 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
899 TREMOR 29 0.0002
900 TINNITUS 8 0.0002
901 EYE IRRITATION 10 0.0002
902 ORTHOSTATIC HYPOTENSION 3 0.0002
903 UNEVALUABLE EVENT 13 0.0002
904 BLOOD CHOLESTEROL INCREASED 8 0.0002
905 AMENORRHOEA 3 0.0002
906 HYPOXIA 6 0.0002
907 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
908 COLORECTAL CANCER 8 0.0002
909 GASTROENTERITIS VIRAL 3 0.0002
910 LOCALISED INFECTION 4 0.0002
911 WEIGHT INCREASED 37 0.0002
912 HYPOGLYCAEMIA 8 0.0002
913 ILL-DEFINED DISORDER 10 0.0002
914 BLOOD GLUCOSE ABNORMAL 3 0.0002
915 NECK PAIN 9 0.0002
916 SWOLLEN TONGUE 5 0.0002
917 LEUKOPENIA 8 0.0002
918 ANGIOEDEMA 7 0.0002
919 PULMONARY FIBROSIS 3 0.0002
920 LOWER LIMB FRACTURE 3 0.0002
921 HIP FRACTURE 5 0.0002
922 UNRESPONSIVE TO STIMULI 4 0.0002
923 EAR PAIN 3 0.0002
924 ORAL HERPES 3 0.0002
925 SKIN BURNING SENSATION 11 0.0002
926 STAPHYLOCOCCAL INFECTION 5 0.0002
927 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
928 EXPIRED PRODUCT ADMINISTERED 5 0.0002
929 FUNGAL INFECTION 5 0.0001
930 EYE PRURITUS 5 0.0001
931 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
932 LIMB INJURY 4 0.0001
933 PALLOR 4 0.0001
934 MIGRAINE 14 0.0001
935 DIABETES MELLITUS 11 0.0001
936 BLOOD GLUCOSE INCREASED 27 0.0001
937 PAIN IN JAW 4 0.0001
938 JOINT INJURY 3 0.0001
939 IRRITABLE BOWEL SYNDROME 3 0.0001
940 CHEST DISCOMFORT 14 0.0001
941 RESTLESSNESS 5 0.0001
942 NASOPHARYNGITIS 25 0.0001
943 RENAL INJURY 4 0.0001
944 NERVOUSNESS 7 0.0001
945 DYSARTHRIA 5 0.0001
946 HOT FLUSH 10 0.0001
947 DISCOMFORT 8 0.0001
948 FEMUR FRACTURE 4 0.0001
949 HEAD INJURY 4 0.0001
950 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
951 RHINORRHOEA 8 0.0001
952 LACTIC ACIDOSIS 4 0.0001
953 EXTRA DOSE ADMINISTERED 5 0.0001
954 FEELING HOT 7 0.0001
955 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
956 ABNORMAL DREAMS 3 0.0001
957 TREATMENT FAILURE 9 0.0001
958 PROCEDURAL PAIN 3 0.0001
959 SINUSITIS 11 0.0001
960 CHRONIC KIDNEY DISEASE 8 0.0001
961 MUSCULOSKELETAL STIFFNESS 9 0.0001
962 ANXIETY 29 0.0001
963 IRRITABILITY 6 0.0001
964 EMOTIONAL DISORDER 3 0.0001
965 RHEUMATOID ARTHRITIS 11 0.0001
966 DEPRESSION 22 0.0001
967 ROAD TRAFFIC ACCIDENT 4 0.0001
968 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
969 BRADYCARDIA 5 0.0001
970 OSTEONECROSIS 3 0.0001
971 THERAPY NON-RESPONDER 4 0.0001
972 DRUG INEFFECTIVE 116 0.0001
973 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
974 SKIN IRRITATION 4 0.0001
975 NASAL CONGESTION 5 0.0001
976 PSORIATIC ARTHROPATHY 3 0.0001
977 DYSKINESIA 3 0.0001
978 TREATMENT NONCOMPLIANCE 4 0.0001
979 MEDICATION ERROR 4 0.0001
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
981 PSORIASIS 9 0.0001
982 BRONCHITIS 5 0.0001
983 WHEEZING 4 0.0001
984 COMA 3 0.0001
985 NO ADVERSE EVENT 11 0.0001
986 ASTHMA 5 0.0000
987 SUICIDAL IDEATION 4 0.0000
988 AGITATION 3 0.0000
989 OVERDOSE 8 0.0000
990 PRODUCT STORAGE ERROR 3 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
992 INCORRECT DOSE ADMINISTERED 6 0.0000